Usana Health Sciences (USNA) EV to CFO (2011 - 2026)

Usana Health Sciences (USNA) has reported EV to CFO for 16 consecutive years, with 11.72 the latest figure, recorded in Q3 2026.

• On a quarterly basis, EV to CFO fell 69.65% year-over-year to 11.72 in Q3 2026; TTM through Jul 2026 was 9.85, a 31.67% increase from a year earlier, with the FY2026 full-year figure at 11.19, up 23.49% from the prior year.
• EV to CFO was 11.72 for Q3 2026 at Usana Health Sciences, down from 20.54 in the prior quarter.
• Over five years, EV to CFO peaked at 197.09 in Q1 2022 and troughed at 218.99 in Q3 2025.
• A 5-year average of 33.35 and a median of 33.67 in 2024 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO soared 257.86% in 2024 and slumped 1908.01% in 2025, its largest moves.
• Over 5 years, EV to CFO stood at 18.12 in 2022, then surged by 47.35% to 26.71 in 2023, then soared by 257.86% to 95.57 in 2024, then sank by 329.15% to 218.99 in 2025, then jumped by 105.35% to 11.72 in 2026.
• The last three EV to CFO figures came in at 11.72 (Q3 2026), 20.54 (Q2 2026), and 73.8 (Q1 2026), per Business Quant data.